468
Views
20
CrossRef citations to date
0
Altmetric
Review Article

Regulatory T cells—the renaissance of the suppressor T cells

, &
Pages 322-334 | Published online: 08 Jul 2009

Figures & data

Table I. Characteristics of naturally occurring (nTregs) and induced T regulatory cells (iTregs).

Figure 1. Tregs—immune modulators in health and disease. Naturally occurring CD4+CD25+ Tregs (nTregs) develop directly from CD4+ T cell precursors during positive selection in the thymus. Induced Tregs (iTregs) develop from naïve conventional CD4+ T cells either as a result of cell contact‐dependent interaction with nTregs or under the influence of suppressive agents like IL‐10, TGF‐β, dexamethasone, vitamin D3, vasoactive intestinal peptide, tolerogenic DC, and potentially other inhibitory mechanisms. Modulation of Treg (nTregs/iTregs) function is a promising intervention strategy to either improve responses in tumor and microbial diseases or suppress those unwanted in autoimmunity, allergy, transplantation, and pregnancy disorders. The transient depletion of Tregs as well as their manipulation, especially via toll‐like receptor (TLR) ligands, allow a transient reduction of Treg activity and enforce antitumor responses and immunity against viral infections. On the other hand their selective activation could diminish chronic pathological immune and autoimmune responses.

Figure 1. Tregs—immune modulators in health and disease. Naturally occurring CD4+CD25+ Tregs (nTregs) develop directly from CD4+ T cell precursors during positive selection in the thymus. Induced Tregs (iTregs) develop from naïve conventional CD4+ T cells either as a result of cell contact‐dependent interaction with nTregs or under the influence of suppressive agents like IL‐10, TGF‐β, dexamethasone, vitamin D3, vasoactive intestinal peptide, tolerogenic DC, and potentially other inhibitory mechanisms. Modulation of Treg (nTregs/iTregs) function is a promising intervention strategy to either improve responses in tumor and microbial diseases or suppress those unwanted in autoimmunity, allergy, transplantation, and pregnancy disorders. The transient depletion of Tregs as well as their manipulation, especially via toll‐like receptor (TLR) ligands, allow a transient reduction of Treg activity and enforce antitumor responses and immunity against viral infections. On the other hand their selective activation could diminish chronic pathological immune and autoimmune responses.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.